In this study, a comprehensive analysis of the potential impact of SGLT2 inhibitors on various psychiatric disorders was conducted through MR analysis, utilizing quantitative trait loci (QTL) and GWAS summary data. The gene discussed is SLC5A2; the disease is psychiatric disorder.